Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis

F Petrelli, A Cortellini, A Indini, G Tomasello… - JAMA Network …, 2021 - jamanetwork.com
Importance Obesity, defined as a body mass index (BMI) greater than 30, is associated with
a significant increase in the risk of many cancers and in overall mortality. However, various …

[HTML][HTML] MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside

M Ratti, A Lampis, M Ghidini, M Salati, MB Mirchev… - Targeted …, 2020 - Springer
Non-coding RNAs represent a significant proportion of the human genome. After having
been considered as 'junk'for a long time, non-coding RNAs are now well established as …

Medical treatment for cholangiocarcinoma

J Adeva, B Sangro, M Salati, J Edeline… - Liver …, 2019 - Wiley Online Library
Most of the patients with cholangiocarcinoma (CCA) present with advanced (inoperable or
metastatic) disease, and relapse rates are high in those undergoing potentially curative …

[HTML][HTML] Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

G Fucà, R Cohen, S Lonardi, K Shitara… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Despite unprecedented benefit from immune checkpoint inhibitors (ICIs) in
patients with mismatch repair deficient (dMMR)/microsatellite instability high (MSI-H) …

[HTML][HTML] Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?

A Botticelli, B Cerbelli, L Lionetto, I Zizzari… - Journal of translational …, 2018 - Springer
Background Immune checkpoint inhibitors have revolutionized the treatment paradigm of
highly lethal malignancies like advanced non-small cell lung cancer (NSCLC) …

[HTML][HTML] The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors

F Corti, S Lonardi, R Intini, M Salati, E Fenocchio… - European journal of …, 2021 - Elsevier
Abstract Background Immune checkpoint inhibitors (ICIs) yielded unprecedented efficacy in
patients with microsatellite instability (MSI)–high metastatic colorectal cancer (mCRC). Since …

[HTML][HTML] Assessing the impact of COVID-19 on liver cancer management (CERO-19)

S Muñoz-Martínez, V Sapena, A Forner, JC Nault… - JHEP reports, 2021 - Elsevier
Background & Aims The coronavirus disease 2019 (COVID-19) pandemic has posed
unprecedented challenges to healthcare systems and it may have heavily impacted patients …

Gastric cancer: translating novels concepts into clinical practice

M Salati, G Orsi, E Smyth, G Beretta, F De Vita… - Cancer treatment …, 2019 - Elsevier
The overall 5-year survival of gastric cancer (GC) has change only little in the last decades
and it remains the fifth leading cause of cancer-related death worldwide. However, in the …

[HTML][HTML] Epidemiological overview of Hodgkin lymphoma across the mediterranean basin

M Salati, M Cesaretti, M Macchia… - … journal of hematology …, 2014 - ncbi.nlm.nih.gov
The epidemiology of Hodgkin lymphoma (HL) has always been a source of fascination to
researchers due to its heterogeneous characteristics of presentation. HL is an uncommon …

[HTML][HTML] A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab

A Botticelli, M Salati, FR Di Pietro, L Strigari… - Journal of Translational …, 2019 - Springer
Background The advent of immune checkpoint inhibitors (ICIs) has considerably expanded
the armamentarium against non-small cell lung cancer (NSCLC) contributing to reshaping …